What are the reactions to discontinuing Novartis?
Nov 20, 2022
Source: Cainiu Health
Dr. Yang Shuwen
Introduction
Discontinuation of Novartis' Entresto (sacubitril/valsartan) may lead to adverse reactions such as vascular rebound and myocardial hypertrophy. Entresto, also known as sacubitril valsartan sodium tablets, is a medication used to treat chronic heart failure. Its main effects include vasodilation, reducing sympathetic nervous system activity, and inhibiting myocardial cell hypertrophy, thereby achieving therapeutic benefits in heart failure.
Discontinuation of Novartis may lead to adverse reactions such as vasodilation and myocardial cell hypertrophy.
Novartis, also known as sacubitril/valsartan sodium tablets, is a medication used to treat chronic heart failure. Its main effects include vasodilation, reducing sympathetic nervous system activity, and inhibiting myocardial cell hypertrophy, thereby helping manage heart failure. This medication should be used strictly under medical supervision; self-medication should be avoided to prevent adverse outcomes. Abruptly stopping the drug may worsen the condition, increase treatment difficulty, and impair recovery. Patients who truly require discontinuation must consult their physician and have their clinical condition evaluated before stopping the medication.
Patients taking Novartis are advised to follow their doctor's instructions regarding dosage and duration of treatment and must not discontinue the drug arbitrarily. Additionally, elderly patients with moderate to severe heart failure should use this medication with caution. During treatment, it is recommended to consume light, easily digestible foods such as pumpkin porridge and steamed buns, which may aid drug absorption.
